LNC Therapeutics raised €6.5M in a Series C round in Aug 2017. The company is based in France. Investors in the round: Seventure Partners. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €6.5M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
